Massachusetts General Hospital, Renal Associates Clinic

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance	Blood Protein Disorders, Hemic and Lymphatic Diseases, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy	Active, not recruiting	Phase 2	2026-07-23		NCT04614558

Clinical trials